Patient-controlled analgesia with remifentanil in a parturient with Ankylosing Spondylitis and SARS-CoV-2 infection: A case report
- Author:
Dominic D. Villa
1
;
Christine Grace A. Suarez
1
;
Jeffrey Paolo M. Nuñez
1
Author Information
- Publication Type:Case Reports
- MeSH: Spondylitis, Ankylosing; Remifentanil; Analgesia, Patient-Controlled; Analgesia, Obstetrical; COVID-19
- From: Acta Medica Philippina 2024;58(9):54-58
- CountryPhilippines
- Language:English
- Abstract: Parturients with both ankylosing spondylitis (AS) and SARS-CoV-2 Infection (COVID-19) present unique challenges to anesthesiologists. Neuraxial analgesia for labor remains the gold standard in obstetric patients. However, in patients with AS, this approach may be deemed difficult to impossible. Administration of systemic opioids for labor analgesia can be an option, bearing in mind the potential respiratory depressant effect to both the mother and the fetus, especially in the setting of concomitant COVID-19. This paper reports the successful management of such a patient using patient-controlled analgesia (PCA) with intravenous remifentanil.
- Full text:20240613115644037868779-Article Text-158455-1-10-20240523.pdf
